Skip to main content
. Author manuscript; available in PMC: 2022 Jul 6.
Published in final edited form as: Liver Transpl. 2021 Jun 24;27(7):1019–1031. doi: 10.1002/lt.26029

Table 1.

Baseline characteristics of liver transplant recipients in the USA between January 1, 2010 and December 31, 2019

All patients (N=27,343) Propensity score-matched patients (n=5124)
LDLT (n=2566) DBD LT (n=24777) p-
value
LDLT* (n=2566) DBD LT (n=2566) p-
value
Donor:
Age (years) 36.0 (28.0, 45.0) 44.0 (29.0, 56.0) <0.001 36.0 (28.0, 45.0) 33.0 (22.0, 48.0) <0.001
BMI (kg/m2) 26.2 (23.5, 28.7) 27.0 (23.5, 31.3) <0.001 26.2 (23.5, 28.7) 26.1 (22.5, 30.6) 0.120
Male gender 1214 (47.3) 14447 (58.3) <0.001 1214 (47.3) 1276 (49.7) 0.083
Caucasian race 2088 (81.4) 15780 (63.7) <0.001 2088 (81.4) 2031 (79.2) 0.050
Cold ischemia (hours)* 1.5 (1.0, 2.1) 4.7 (4.0, 5.4) <0.001 1.5 (1.0, 2.1) 4.7 (3.9, 5.5) <0.001
Recipient:
Age (years) 56.0 (46.0, 63.0) 58.0 (51.0, 63.0) <0.001 56.0 (46.0, 63.0) 56.0 (47.0, 63.0) 0.850
Male gender 1401 (54.6) 16275 (65.7) <0.001 1401 (54.6) 1425 (55.5) 0.500
Caucasian race 2087 (81.3) 17965 (72.5) <0.001 2087 (81.3) 2005 (78.1) 0.004
BMI (kg/m2) 26.3 (23.3, 30.0) 28.1 (24.6, 32.3) <0.001 26.3 (23.3, 30.0) 26.0 (23.2, 29.9) 0.440
Post-transplant LOS (days) 10.0 (8.0, 16.0) 9.0 (6.0, 15.0) <0.001 10.0 (8.0, 16.5) 8.0 (6.0, 12.0) <0.001
Waiting list time (days) 150.0 (78.0, 302.0) 96.0 (18.0, 284.0) <0.001 150.0 (78.0, 302.0) 163.5 (48.0, 351.0) 0.079
Diabetes 607 (23.7) 6627 (26.7) <0.001 608 (23.7) 621 (24.2) 0.920
Serum creatinine (mg/dL) 0.8 (0.7, 1.1) 1.0 (0.8, 1.6) <0.001 0.8 (0.7, 1.1) 0.9 (0.7, 1.1) <0.001
Serum total bilirubin (mg/dL) 2.7 (1.4, 4.8) 3.9 (1.7, 10.9) <0.001 2.7 (1.4, 4.8) 2.0 (1.0, 4.3) <0.001
MELD score 15.0 (11.0, 20.0) 21.0 (13.0, 30.0) <0.001 15.0 (11.0, 20.0) 14.0 (1.0, 20.0) 0.004
Life support requirement 20 (0.8) 1515 (6.1) <0.001 20 (0.8) 42 (1.6) 0.005
ICU 32 (1.2) 2739 (11.1) <0.001 32 (1.2) 70 (2.7) <0.001
Dialysis requirement 16 (0.6) 2374 (9.6) <0.001 16 (0.6) 40 (1.6) 0.001
Ascites (mild or worse) 1628 (63.4) 18518 (74.7) <0.001 1628 (63.4) 1607 (62.6) 0.540
Hepatic encephalopathy (grade 1 or worse) 1285 (50.1) 15565 (62.8) <0.001 1285 (50.1) 1306 (50.9) 0.560
Portal vein thrombosis 295 (11.5) 3092 (12.5) 0.150 295 (11.5) 295 (11.5) 0.280
HCC 450 (17.5) 8326 (33.6) <0.001 450 (17.5) 520 (20.3) 0.013

Values are n (%) or median (interquartile range).

There are 10 propensity-score matched variables presented in italics in this table. In addition, recipients were also matched on transplant year and etiology of liver disease

BMI = body mass index; DBD = donation after brain death; LT = liver transplantation; ICU = intensive care unit; LDLT = living-donor liver transplantation; LOS = length of stay; MELD = model for end-stage liver disease.